A Study of TQ-B3101 Capsules in Subjects With Advanced Malignant Tumor
Clinical trial NCT04412564 · UNKNOWN
Trial details
- NCT number
- NCT04412564
- Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-05
- Primary completion
- 2021-03-31
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.